Effectiveness of SDF With Different Post-treatment Protocols in Arresting Dental Caries

December 8, 2022 updated by: Chun-Hung Chu, The University of Hong Kong

The Effectiveness of Silver Diamine Fluoride Treatment With Different Post-treatment Protocols in Arresting Dental Caries in Primary Teeth of Preschool Children

To compare the effectiveness of the semi-annual application of 38% SDF with two post-treatment protocols in arresting dental caries in preschool children

Study Overview

Detailed Description

Methods: The randomized double blinded clinical trial will recruit 254 healthy kindergarten children aged 3-5 years old with caries and with parental consent. All the tooth surfaces with carious lesions will receive the semi-annual application of 38% SDF solution. After the treatment, children will be allocated to two groups by an independent research assistant. Two post-treatment protocols are as follows.

Group A - Children are instructed to rinse their teeth with a cup of water containing about 50 ml immediately after SDF treatment. Afterwards, no post-treatment protocol is given to children.

Group B - Children are instructed not to eat and drink for at least 30 minutes. Clinical examinations after 6-months will be conducted to assess whether the caries is arrested. Information on confounding factors, such as oral hygiene habits and the use of other fluoride agents, will be collected through a parental questionnaire at the baseline and 12-months follow-up. The examiner, the children and the children's parents will be blind to the treatment allocation. The analysis will determine the significance of differences between the means of arrested caries at the various follow-ups.

Significance: This study will help determine the optimal post-op treatment in SDF treatment. The study provides an evidence-based protocol for the use of silver diamine fluoride to arrest tooth decay in primary teeth of young children.

Study Type

Interventional

Enrollment (Anticipated)

254

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Chun Hung Chu, PhD
  • Phone Number: (+852)28590287
  • Email: chchu@hku.hk

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 year to 3 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. 3-5 year old children attending the first to the third year of kindergarten;
  2. free from any systemic conditions and generally healthy;
  3. parents sign informed consent;
  4. having at least 1 tooth with cavitated dentine carious lesion

Exclusion Criteria:

  1. are uncooperative to accept oral examination or treatment;
  2. have a significant systematic disease or long-term medications;
  3. have abnormal dentition.
  4. Teeth having signs or symptoms of irreversible pulpitis and non-vitality will be excluded.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group A- immediately rinse mouth
Children are instructed to rinse their teeth with a cup of water containing about 50 ml immediately after SDF treatment. Afterwards, no post-treatment protocol is given to children.
Children with active caries will receive 38% silver diamine fluoride treatment
After receiving 38% silver diamine fluoride treatment, Children will be asked to rinse their mouths immediately.
Experimental: Group B- not to rinse for at least 30 minutes
Children are instructed not to eat and drink for at least 30 minutes.
Children with active caries will receive 38% silver diamine fluoride treatment
After receiving 38% silver diamine fluoride treatment, Children will be asked not to rinse their mouths for at least 30 minutes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Caries status
Time Frame: at 12-month follow-up
The proportion of the soft (active) carious tooth lesion surfaces that harden (arrested) at 12 months of follow-up will be measured
at 12-month follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The visible plaque index (VPI)
Time Frame: at 12-month follow-up
Two areas (buccal and lingual) of each of the six index teeth (55/51/63/71/75/83) will be examined and recorded (presence/absence) the status of visible plaque.
at 12-month follow-up
dmft index
Time Frame: at 12-month follow-up
The caries experience will be recorded to assess the caries increment by using dmft index at baseline and 12 months later
at 12-month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

January 1, 2023

Primary Completion (Anticipated)

June 30, 2024

Study Completion (Anticipated)

December 30, 2024

Study Registration Dates

First Submitted

November 30, 2022

First Submitted That Met QC Criteria

December 8, 2022

First Posted (Actual)

December 19, 2022

Study Record Updates

Last Update Posted (Actual)

December 19, 2022

Last Update Submitted That Met QC Criteria

December 8, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dental Caries

Clinical Trials on 38% SDF treatment

3
Subscribe